Top Story

Palivizumab prophylaxis for RSV requires more definitive data

November 22, 2014

NEW YORK — In light of the AAP’s recent recommendations on palivizumab for treatment of respiratory syncytial virus, benefits and disadvantages of the treatment were discussed during a keynote address at the 2014 Infectious Diseases in Children Symposium.

H. Cody Meissner, MD, an Infectious Diseases in Children Editorial Board member, led the discussion, touching on the overall burden of RSV among all age groups, historical background on the treatment of RSV and the AAP’s guidance regarding RSV immunoprophylaxis.

thumbnail for video 3904927585001 Meeting News CoverageVideo

Early doxycycline treatment needed to address tick-borne rickettsial disease

November 22, 2014
NEW YORK — Gordon E. Schutze, MD, professor of pediatrics and retrovirology at the Baylor College of Medicine, discusses treatment for the range of lesser-known…

CDC: Respiratory illness reports rising, enterovirus D68 cases decline

November 21, 2014
While many states are experiencing reductions in the number of new enterovirus D68-associated illnesses, the CDC recently has received data indicating that some states…
In the Journals

Pathogens causing skin, soft tissue infections found in hidradenitis suppurative lesions

November 21, 2014
Hidradenitis suppurativa lesions appeared to contain bacterial pathogens known to cause skin and soft tissue infections, according to researchers from France. In a…
Meeting News Coverage

TURQUOISE-II: Demographics, viral factors did not predict SVR after 3D regimen

November 21, 2014
BOSTON — Sustained virologic response rates after treatment with an all-oral regimen of coformulated ABT-450 boosted with ritonavir, ombitasvir and dasabuvir plus…
More News Headlines »

CRITICAL ISSUES IN HBV: Considerations in Optimizing HBV Treatment

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »
Meeting News Coverage Video
thumbnail for video 3899432251001

New HCV treatments could reduce mortality, but increase costs by billions

November 19, 2014
BOSTON – In this video exclusive from The Liver Meeting, David B. Rein, PhD, MPA, of the National Opinion…
More »
J490 Challenges in HIV Screening

Challenges in HIV Screening and Prophylaxis: PrEP’ing for the Future

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

A substantial proportion of Americans with HIV remain undiagnosed and suboptimally treated. Failure to follow…
More »